Biomarkers in Transplant Recipients to Improve Outcomes
NCT01163578 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1200
Last updated 2025-09-09
Summary
The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.
Conditions
- Solid Organ Transplantation
- Bone Marrow Transplantation
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Rakesh Sindhi, MD · University of Pittsburgh
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-03-31
- Primary Completion
- 2030-03-31
- Completion
- 2030-03-31
Countries
- United States
Study Locations
More Related Trials
-
Investigating Cytokine Genes of Stem Cell Donors
NCT00353821 ·Status: COMPLETED
-
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
NCT03541889 ·Status: RECRUITING ·Phase: PHASE1
-
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation
NCT04428918 ·Status: WITHDRAWN
-
Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
NCT06102694 ·Status: RECRUITING
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
NCT05866302 ·Status: RECRUITING
-
Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment
NCT04571203 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Markers of Inflammation in Hematopoietic Stem Cell Transplant
NCT00579397 ·Status: COMPLETED
-
Improving Blood Stem Cell Collection and Transplant Procedures
NCT01517035 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
NCT01174277 ·Status: COMPLETED
-
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
NCT00106925 ·Status: RECRUITING
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Musculoskeletal Outcomes After Bone Marrow Transplant
NCT00558948 ·Status: COMPLETED
-
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
NCT03500731 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies
NCT00079391 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients
NCT03659773 ·Status: COMPLETED ·Phase: NA
-
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
NCT01852370 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
NCT02579967 ·Status: RECRUITING ·Phase: PHASE2
-
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
NCT00898612 ·Status: WITHDRAWN
-
Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.
NCT06208137 ·Status: RECRUITING ·Phase: NA
-
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
NCT02934477 ·Status: RECRUITING
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
Effect of BM-MSCs on Chronic AMR After Kidney Transplantation
NCT02563340 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
NCT00957736 ·Status: TERMINATED
-
Pipeline Integrating Gut Metagenome Data, Host Immunogenetic Characteristics and Clinical Gut Inflammatory Biomarkers
NCT02940093 ·Status: UNKNOWN